ArticleScientific reports2026

PBPK modeling predicts rilzabrutinib dose adjustments using BTK occupancy for CYP3A4 interactions and hepatic impairment.

Xiaoping Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.